ABBOTT LABORATORIES — Director's Dealing 2005

Mar 10, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-03-08

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-03-08	Common shares without par value	M	15894	$41.9715	Acquired	202014	Direct
2005-03-08	Common shares without par value	M	35468	$33.2314	Acquired	237482	Direct
2005-03-08	Common shares without par value	F	44219	$46.65	Disposed	193263	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-03-08	Option (right to buy)	$41.9715	M	15894	Disposed	2005-04-27	common shares (15894)	Direct
2005-03-08	Option (right to buy)	$33.2314	M	35468	Disposed	2013-02-13	common shares (35468)	Direct
2005-03-08	Option (right to buy)	$46.65	A	29290	Acquired	2013-02-13	common shares (29290)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17118	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 8, 2005.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.